scholarly article | Q13442814 |
P356 | DOI | 10.4088/JCP.10M06743 |
P698 | PubMed publication ID | 21658349 |
P50 | author | Conrad P Earnest | Q37378215 |
Steven Blair | Q61196520 | ||
Madhukar Trivedi | Q87600331 | ||
Timothy S Church | Q96143449 | ||
P2093 | author name string | Bruce D Grannemann | |
Daniel I Galper | |||
Steven S Henley | |||
Andrea L Dunn | |||
Thomas J Carmody | |||
Tracy L Greer | |||
Prabha Sunderajan | |||
P433 | issue | 5 | |
P921 | main subject | major depressive disorder | Q42844 |
P304 | page(s) | 677-684 | |
P577 | publication date | 2011-05-01 | |
P1433 | published in | The Journal of Clinical Psychiatry | Q7743563 |
P1476 | title | Exercise as an augmentation treatment for nonremitted major depressive disorder: a randomized, parallel dose comparison | |
P478 | volume | 72 |
Q30383857 | A Randomized Controlled Trial of Mindfulness-Based Cognitive Therapy for Treatment-Resistant Depression. |
Q36387054 | A pilot study of women's affective responses to common and uncommon forms of aerobic exercise |
Q36288038 | A preliminary, randomized trial of aerobic exercise for alcohol dependence |
Q36743908 | Aerobic Exercise for Reducing Migraine Burden: Mechanisms, Markers, and Models of Change Processes |
Q38388409 | Affect Following First Exercise Session as a Predictor of Treatment Response in Depression |
Q34791332 | Association between physical activity and depressive symptoms: midlife women in SWAN. |
Q61440471 | Association between physical exercise and mental health in 1·2 million individuals in the USA between 2011 and 2015: a cross-sectional study |
Q42158020 | Atypical depressive symptoms as a predictor of treatment response to exercise in Major Depressive Disorder |
Q26782997 | Challenging Treatment-Resistant Major Depressive Disorder: A Roadmap for Improved Therapeutics |
Q39328768 | Consensus Recommendations for the Clinical Application of Repetitive Transcranial Magnetic Stimulation (rTMS) in the Treatment of Depression |
Q34464962 | DEMO-II trial. Aerobic exercise versus stretching exercise in patients with major depression-a randomised clinical trial |
Q37712388 | Daily activity level improvement with antidepressant medications predicts long-term clinical outcomes in outpatients with major depressive disorder |
Q26785999 | Depression and Exercise: A Clinical Review and Management Guideline |
Q50531989 | Depressive Symptom Dimensions and Their Association with Hippocampal and Entorhinal Cortex Volumes in Community Dwelling Older Adults. |
Q46674667 | Does exercise improve self-reported sleep quality in non-remitted major depressive disorder? |
Q55364555 | Effects of a 12-week running programme in youth and adults with complex mood disorders. |
Q37345200 | Effects of creatine monohydrate supplementation and exercise on depression-like behaviors and raphe 5-HT neurons in mice |
Q41086751 | Evaluation of anhedonia with the Snaith-Hamilton Pleasure Scale (SHAPS) in adult outpatients with major depressive disorder |
Q30382252 | Exercise Augmentation of Exposure Therapy for PTSD: Rationale and Pilot Efficacy Data |
Q36243437 | Exercise as an adjunct treatment for opiate agonist treatment: review of the current research and implementation strategies |
Q48012950 | Exercise augmentation compared with usual care for post-traumatic stress disorder: a randomized controlled trial. |
Q24198097 | Exercise for depression |
Q38092181 | Exercise in the treatment of major depression: a systematic review grading the quality of evidence |
Q47364349 | Exercise is an effective treatment for positive valence symptoms in major depression |
Q38664894 | Exercise training - A beneficial intervention in the treatment of alcohol use disorders? |
Q36043319 | IL-1β and BDNF are associated with improvement in hypersomnia but not insomnia following exercise in major depressive disorder. |
Q39778779 | IMPROVEMENTS IN PSYCHOSOCIAL FUNCTIONING AND HEALTH-RELATED QUALITY OF LIFE FOLLOWING EXERCISE AUGMENTATION IN PATIENTS WITH TREATMENT RESPONSE BUT NONREMITTED MAJOR DEPRESSIVE DISORDER: RESULTS FROM THE TREAD STUDY. |
Q47694934 | Immune-based strategies for mood disorders: facts and challenges |
Q41173157 | Immunological effects of behavioral activation with exercise in major depression: an exploratory randomized controlled trial |
Q26745562 | Impact of Exercise on Innate Immunity in Multiple Sclerosis Progression and Symptomatology |
Q37310533 | Inflammation and Immune Regulation as Potential Drug Targets in Antidepressant Treatment. |
Q34493536 | Inflammation: depression fans the flames and feasts on the heat |
Q36733303 | Is Exercise an Efficacious Treatment for Depression? A Comment upon Recent Negative Findings |
Q39292984 | Jogging Therapy for Hikikomori Social Withdrawal and Increased Cerebral Hemodynamics: A Case Report |
Q47793403 | Long-term effects of exercise at different intensity levels on depression: A randomized controlled trial |
Q34511957 | MAP training: combining meditation and aerobic exercise reduces depression and rumination while enhancing synchronized brain activity |
Q37981491 | Neuroglialpharmacology: myelination as a shared mechanism of action of psychotropic treatments |
Q35984653 | Optimizing the Exercise Prescription for Depression: The Search for Biomarkers of Response |
Q47556460 | Personalized Antidepressant Selection and Pathway to Novel Treatments: Clinical Utility of Targeting Inflammation |
Q37136799 | Physical activity in depressed elderly. A systematic review. |
Q30217599 | Physical activity patterns among U.S. adults with and without serious psychological distress |
Q36100305 | Pioglitazone adjunctive therapy for moderate-to-severe major depressive disorder: randomized double-blind placebo-controlled trial. |
Q64067030 | Prediction of Acute-Phase Treatment Outcomes by Adding a Single-Item Measure of Activity Impairment to Symptom Measurement: Development and Validation of an Interactive Calculator from the STAR*D and CO-MED Trials |
Q47838168 | Prediction of treatment outcomes to exercise in patients with nonremitted major depressive disorder. |
Q41020780 | Predictors of depression outcomes among abstinent methamphetamine-dependent individuals exposed to an exercise intervention |
Q41703239 | Predictors of depression outcomes among abstinent methamphetamine-dependent individuals exposed to an exercise intervention |
Q36438114 | Pro-inflammatory cytokines as predictors of antidepressant effects of exercise in major depressive disorder |
Q34427065 | Rationale for Using Exercise in the Treatment of Stimulant Use Disorders |
Q44771340 | Re: a new discussion for "The projected effect of increasing physical activity on reducing the prevalence of common mental disorders among Canadian men and women: a national population-based community study". |
Q34067359 | Role of the dorsal medial habenula in the regulation of voluntary activity, motor function, hedonic state, and primary reinforcement |
Q36827478 | STimulant Reduction Intervention using Dosed Exercise (STRIDE) - Description of the Exercise Intervention and Behavioral Program to Ensure Adherence |
Q36246443 | Sedentary behavior and physical activity are independent predictors of successful aging in middle-aged and older adults |
Q38569937 | The prevalence, measurement, and treatment of the cognitive dimension/domain in major depressive disorder |
Q36524243 | The pro-inflammatory profile of depressed patients is (partly) related to obesity |
Q39510397 | The projected effect of increasing physical activity on reducing the prevalence of common mental disorders among Canadian men and women: a national population-based community study |
Q38543238 | Towards new mechanisms: an update on therapeutics for treatment-resistant major depressive disorder |
Q40626205 | Training fast or slow? Exercise for depression: A randomized controlled trial |
Q36583311 | Treating depression and depression-like behavior with physical activity: an immune perspective |
Q47601841 | Treating depression with physical activity in adolescents and young adults: a systematic review and meta-analysis of randomised controlled trials |
Q38300376 | Understanding the role of adjunctive nonpharmacological therapies in management of the multiple pathways to depression |
Search more.